Found 1 publication. Displayed publication 1
Expand all publications       Show all as text (SweetDB notation)

1. (Article ID: 12024)
 
Bedir E, Pugh N, Calis I, Pasco DS, Khan IA
Immunostimulatory effects of cycloartane-type triterpene glycosides from Astragalus species
Biological and Pharmaceutical Bulletin 23(7) (2000) 834-837
 

In the course of our research on the oligoglycosidic constituents of Turkish Astragalus species, we have isolated a number of cycloartane-type triterpene glycosides. The current study examines the immunostimulatory effects of nineteen of these cycloartane-type compounds using a transcription-based bioassay for Nuclear Factor kappa B (NF-κB) activation in a human macrophage/monocyte cell line, THP-1. All compounds were inactive at 100 μg/ml except astragaloside I which increased NF-κB directed luciferase expression to levels about 65% as compared with maximal stimulation by E. coli lipopolysaccharide (LPS) at 10 μg/ml. None of the compounds were active at low dosage levels (0.1 μg/ml) in combination with 50 ng/ml LPS. Astragaloside I also increased mRNA expression of the inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) as measured using reverse transcriptase-polymerase chain reaction (RT)-PCR. Based on these results it is clear that certain structural features are required for immunostimulation of cycloartane-type triterpene glycosides.

macrophage, immunostimulatory, THP-1, Astragalus, astragaloside I, nuclear factor kappa B (NF-κB)

The publication contains the following compound(s):
 

Expand this publication

Resort publications by:

New query Export IDs Home Help

Execution: <1 sec